14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session X : Cell death in cancer Poster X, 91<br />

Functional analysis of the tumorsuppressor Ras Association Family Domain 1<br />

(RASSF1A) reveals an important role of the SARAH-domain<br />

Claudia Seidel, Antje Klagge, Reinhard Dammann<br />

AWG Tumor Genetics of the Medical Faculty, Martin-Luther-University Halle-<br />

Wittenberg, 06097 Halle/Saale, Germany<br />

INTRODUCTION: RASSF1A is a tumor suppressor gene, which is often epigenetically<br />

inactivated in several cancer types. In lung cancer, a rate of between 30 to 45% of<br />

hypermethylation of the RASSF1A promoter has been found. In several cancer types a<br />

correlation between hypermethylation of RASSF1A <strong>and</strong> an impaired prognosis for cancer<br />

patients was reported. The promoter of the RASSF1C isoform is never hypermethylated. The<br />

two isoforms RASSF1A <strong>and</strong> RASSF1C only differ in the first domain, which is a<br />

diacylglycerol binding site <strong>and</strong> lacks in RASSF1C. Moreover RASSF1A encodes a Ras<br />

association domain <strong>and</strong> a SARAH domain, which is a protein-protein interaction domain.<br />

METHODS: In order to investigate the function of RASSF1A, we created mutations <strong>and</strong><br />

deletions of these different domains <strong>and</strong> performed functional experiments in the lung cancer<br />

cell line A549. Proliferation analyses as well as soft agar experiments were performed to<br />

investigate the influence of the aberrant RASSF1A forms. The ability of the different forms of<br />

RASSF1A to induce apoptosis was investigated. To analyse the localisation of RASSF1A <strong>and</strong><br />

its altered forms the cells were transient transfected using Yellow Fluorescent Protein (YFP)<br />

constructs. Additionally, the interaction of RASSF1A with the proapoptotic kinase MST1 was<br />

determined in precipitation experiments with protein extract from human cells.<br />

RESULTS: The reduced proliferation of A549 cells that express RASSF1A could be<br />

confirmed. Analysis of cells stable transfected with RASSF1A with a deletion of the SARAH<br />

domain (RASSF1ADelSARAH) showed a even lower proliferation rate in comparison to<br />

RASSF1A. A higher rate of apoptosis in cells with RASSF1ADelSARAH could be observed<br />

using transient transfected cells. RASSF1A is when overexpressed as a YFP-fusion<br />

colocalised to the cytoskeleton <strong>and</strong> during mitosis to the spindles <strong>and</strong> spindle poles. Using<br />

RASSF1ADelSARAH the mitoses show strong spindles no spindle poles <strong>and</strong> the<br />

chromosomes are not divided equally. In precipitation experiments MST1 interacts with<br />

RASSF1A but not with RASSF1ADelSARAH.<br />

CONCLUTIONS: The SARAH domain is necessary for the function of the tumor suppressor<br />

RASSF1A. It is responsible for the interaction with MST1 <strong>and</strong> plays an important role in<br />

regulation of mitotic processes as well as in induction of apoptosis.<br />

This study was supported by BMBF grant 01ZZ0104.<br />

- 424 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!